Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print
Other options

view Contact Information


Contact Information for Pembrolizumab with Lenvatinib in Previously Treated Advanced Triple Negative Breast Cancer

The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org

City of Hope ( Site 0002), Duarte, CA,  91010

Contact person: Study Coordinator
Phone:626-218-9200

University of California Davis Comprehensive Cancer Center ( Site 0005), Sacramento, CA,  95817

Contact person: Study Coordinator
Phone:916-734-3772

University of Colorado, Anschutz Cancer Pavilion ( Site 0007), Aurora, CO,  80045

Contact person: Study Coordinator
Phone:720-848-0691

University of Florida-Health Cancer Center-Orlando ( Site 0015), Orlando, FL,  32806

Contact person: Study Coordinator
Phone:321-841-6626

Rutgers Cancer Institute of New Jersey ( Site 0009), New Brunswick, NJ,  08903

Contact person: Study Coordinator
Phone:732-235-8991

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023), New York, NY,  10016

Contact person: Study Coordinator
Phone:212-731-5076

West Cancer Center - East Campus ( Site 0018), Germantown, TN,  38138

Contact person: Study Coordinator
Phone:901683005561236

Swedish Medical Center ( Site 0021), Seattle, WA,  98104

Contact person: Study Coordinator
Phone:206-320-3542

University of Wisconsin Carbone Cancer Center ( Site 0017), Madison, WI,  53792

Contact person: Study Coordinator
Phone:608-262-5223